Waisman Biomanufacturing
Biotechnology Research • 
Shorewood Hills, Wisconsin, United States • 21-50 Employees
Company overview
| Headquarters | 1500 Highland Ave, Madison, WI 53705, US |
| Phone number | +16082629547 |
| Website | |
| NAICS | 541714 |
| Keywords | Biotherapeutics, Vaccines, Recombinant Proteins, Cell Therapies, Gene Therapies |
| Founded | 2001 |
| Employees | 21-50 |
| Socials |
Key Contacts at Waisman Biomanufacturing
Brian Dattilo
Director, Business Development
Chris Bartley
Managing Director
Rita S.
Director Of Quality Control
Waisman Biomanufacturing Email Formats
Waisman Biomanufacturing uses 1 email format. The most common is {first name}{last name} (e.g., johndoe@wisc.edu), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@wisc.edu | 100% |
About Waisman Biomanufacturing
Waisman Biomanufacturing (WB) provides cGMP manufacturing services to serve biotech companies, researchers, and clinicians in the development of novel biotherapeutics for clinical trials. Since opening its cGMP facility in 2001, WB has manufactured over 320 clinical grade products and has earned a reputation for working closely with clients for cost effective and timely manufacture of quality products. We strive to meet these high standards with each product campaign. With in-depth experience in manufacturing a wide range of biotherapeutics for human clinical trials including gene therapeutics, cell therapeutics, vaccines, and recombinant proteins WB is well situated to move your therapy into clinical trial. WB has developed platform manufacturing processes and analytical methods to support clinical production of several classes of biotherapeutics including plasmid DNA, Mesenchymal Stromal Cells (MSCs), human Embryonic Stem Cells (hESCs), adenoviral vectors, lentiviral vectors and AAV. In addition, WB has supported the development and clinical production of a number of novel types of biotherapeutics from process development through to aseptic fill and finish. With a broad range of experience in product development and clinical production, WB has the insight and expertise to identify and address key issues as we work with you to produce your clinical trial material. WB also provides full support for your Investigational New Drug (IND) filing by providing QA audited batch records, Chemistry, Manufacturing, and Control (CMC) support and access to the Waisman Biomanufacturing Type V Facility Master File. Visit us at www.gmpbio.org
Waisman Biomanufacturing revenue & valuation
| Annual revenue | $4,345,292 |
| Revenue per employee | $136,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $14,000,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Waisman Biomanufacturing has 12 employees across 3 departments.
Departments
Number of employees
Funding Data
Waisman Biomanufacturing has never raised funding before.
Waisman Biomanufacturing Tech Stack
Discover the technologies and tools that power Waisman Biomanufacturing's digital infrastructure, from frameworks to analytics platforms.
Security
JavaScript libraries
Tag managers
Hosting
Reverse proxies
Miscellaneous
Miscellaneous
Analytics
Font scripts
United Arab Emirates
Frequently asked questions
4.8
40,000 users
